综述了含糖聚合物作为药物缓释载体应用的新进展。
In this paper, the recent progress of glycopolymer, which applied as drug carrier, is briefly reviewed.
本聚合物及其胶束是一种性能良好的药物缓释载体材料。
The polymer and the micelle thereof are well-behaved carrier materials for the slow release of the medicines.
一种制备兽用药物缓释微粒的方法，属于药品制备领域。
The invention relates to a method for preparing drug slow-releasing particulates for animals, belonging to the field of drug preparation.
可以通过调节这些因素来制备释放时间不同的药物缓释剂。
We can adjust these factors to produce different drug controlled release agent.
本文就纤堆蛋白胶—药物缓释系统的研究及临床应用作以综述。
In this paper, the study and clinical application of fibrin glue-drug sustained release system were reviewed.
高效液相色谱法测定血浆中布比卡因浓度及进行药物缓释作用测定。
HPLC method was used to detect the concentration and releasing effect of bupivacaine in blood serum.
这些聚集体被用在药物运输、药物缓释、生物材料及组织工程等领域。
They are used in the area of drug delivery, drug release, biomaterials and tissue engineering, et al.
结果与结论多肽、蛋白质药物缓释微球在药学领域有着广阔的发展前景。
Results and Conclusions Polypeptide-protein microspheres have broad prospects in the pharmaceutical filed.
目的比较可生物降解药物缓释体与单纯抗瘤药物体外抗胶质瘤细胞的作用。
Objective To compare in vitro antitumor effects of controlled biodegradable drug release system and simplex anti-tumor drug in the patients with glioma.
建立一种新型的药物缓释系统，以研究抗炎药萘普生在该系统中的释放规律。
A newly intelligent drug delivery system was established to research the releasing of naproxen in the systems.
目的：观察应用药物缓释剂和卡介苗构建大鼠局限性炎性肉芽肿模型的效果。
Aim: to explore the effects of granulomatous inflammation model in rats established by the application of drug sustained release and Bacillus Calmette-Guerin (BCG).
实验中还考察了酒石酸布托啡诺在力学性能较好的一种支架中的药物缓释情况。
The drug released from the self-assembly scaffolds was investigated in this research, too.
超支化聚合物在合成嵌段共聚物、涂料、药物缓释剂等方面具有广泛的应用前景。
The polymers had good applied prospects in synthesizing block copolymers, coating, slow releasing agent for medicine, etc.
载药磷酸钙骨水泥是一种集骨修复和局部药物缓释于一体的新型硬组织修复材料。
Calcium phosphate cements (CPC) are used for bone defect filling and may also be used as delivery systems for active agents.
因此，在吸附、离子交换、药物缓释、阻燃材料、催化等方面具有巨大的应用前景。
Thus, it show wide application prospects in the fields of absorption, drug retarded release, fire-retardant and catalysis etc.
当空心微球包裹有药物、酶或催化剂时，可应用于药物缓释、酶固定化和催化剂领域。
The hollow microsphere can be applied in the fields of drug controlled release, enzyme fixation and catalyst when wrapping drug, enzyme or catalyst.
方法：对采用自行研制的海藻酸药物缓释纤维敷料治疗80例患者，进行临床观察研究。
Methods 80 patients treated with the new wound dressing of sustained-release alginate fiber were clinically observed.
目的：综合分析硅橡胶在人造器官设计、医疗器械、整容术和在药物缓释体系的应用意义。
OBJECTIVE: To comprehensively analyze the application values of silicon rubber in the design of artificial organs, medical apparatus, facial plastic surgery and medical release system.
本发明的壳聚糖甲基丙烯酸酯可以用于制造组织工程支架材料，药物缓释材料和酶固定剂。
The chitosan methacrylate can be used for manufacturing tissue engineering support materials, medicine slow release materials and enzyme fixing agents.
既利用透明质酸对癌细胞的靶向性，提高了紫杉醇的生物利用度，又达到了药物缓释的效果。
HA with a specific targeting property could increase the bioavailability of paclitaxel and control the release rate of the drug.
经药物释放动力学的测试和灭菌效果试验表明，该材料具有较长的药物缓释周期和很好的抗菌活性。
The results of experiments of antibiotic release rates and antiseptic studies showed that the material has effective antibiotic activity.
这种鸟巢状多孔hap材料在人工骨植入、骨组织工程支架、药物缓释载体领域有潜在的开发价值。
Therefore, this experiment synthetic porous HAP nest material has the potential development value in bone implanted, bone tissue engineering, drug delivery field.
利用C6胶质瘤细胞在药物缓释体中培养后计算细胞抑制率(IR)验证药物缓释体的缓释杀瘤效果。
Cell inhibition rate (IR) was calculated after C6 glioma cells were cultured in the controlled drug release system for testifying tumor-killing effect of the controlled drug release system.
目的：探讨壳聚糖在脑组织中的生物相容性，为临床提供新型、可用于颅内植入化疗的药物缓释载体。
OBJECTIVE to evaluated the biocompatibility of chitosan in rat brain and to provide a macromolecule sustained release drug delivery system for intracranial implantable chemotherapy.
本发明提供的是一种左旋多巴(L - DOPA)改性有机-无机复合药物缓释支架涂层的制备方法。
The invention relates to a preparation method of an L-DOPA (levodopa) modified organic-inorganic composite medicine slow release stent coating.
海绵的吸水率和保水率、药物缓释性能以及酶降解性能随聚乙烯醇与壳聚糖、明胶混合比例的改变而改变。
The results show that the water uptake ability, the water maintenance ability, drug release efficiency and degradable behavior are related to the proportion of components in the sponge.
目的：探讨壳聚糖在脑组织中的生物相容性，以期为临床提供可用于颅内植入化疗的药物缓释高分子载体。
OBJECTIVE:To explore the biocompatibility of chitosan in brain tissues in order to provide slow released macromolecule carrier for clinically used chemotherapy.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行简要的介绍。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本发明的聚合物主要应用于水溶性药物缓释包衣，添加少许不溶性成份或致孔剂即可达到满意的缓释效果。
The polymer is mainly applied to the water soluble drug sustained release coating, and can reach a satisfied sustained release effect by adding a few insoluble components or pore-forming agents.
复方载药膜的红外光谱证明了这种相互作用的存在，验证了二维紫外相关光谱在药物缓释领域的潜在应用价值。
FTIR spectra of drug-containing PMMA film confirmed the existence of the interaction and the potential applications of two-dimensional UV correlation spectroscopy in drug release have been confirmed.
应用推荐